140 related articles for article (PubMed ID: 1553381)
1. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
Gros P; Teplyakov AV; Hol WG
Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
[TBL] [Abstract][Full Text] [Related]
2. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
McPhalen CA; James MN
Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content.
Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG
J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655
[TBL] [Abstract][Full Text] [Related]
4. Predicting proteinase specificities from free energy calculations.
Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
6. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
7. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
[TBL] [Abstract][Full Text] [Related]
8. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
[TBL] [Abstract][Full Text] [Related]
9. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
10. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
Apostoluk W; Otlewski J
Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
[TBL] [Abstract][Full Text] [Related]
11. [Crystal structure of thermitase and stability of subtilisins].
Tepliakov AV; Kuranova IP; Arutiunian EG; Frömmel C; Höhne WE
Bioorg Khim; 1990 Apr; 16(4):437-47. PubMed ID: 2198028
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
13. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
[TBL] [Abstract][Full Text] [Related]
14. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.
Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL
J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
16. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.
Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG
J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167
[TBL] [Abstract][Full Text] [Related]
17. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution.
Hipler K; Priestle JP; Rahuel J; Grütter MG
FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678
[TBL] [Abstract][Full Text] [Related]
19. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
Huang K; Lu W; Anderson S; Laskowski M; James MN
Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic refinement by incorporation of molecular dynamics: thermostable serine protease thermitase complexed with eglin c.
Gros P; Fujinaga M; Dijkstra BW; Kalk KH; Hol WG
Acta Crystallogr B; 1989 Oct; 45 ( Pt 5)():488-99. PubMed ID: 2688688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
